Botox Injections (Botulinum Toxin Type A)

• Targeted effects: Reduced muscle contraction (smoothing of wrinkles, decreased spasticity). Diminished sweat production (in hyperhidrosis).
• Common side effects: Mild pain, bruising, or edema at the injection site. Temporary asymmetry (e.g., eyebrow ptosis, uneven smile).
• Red flags (rare but serious):
  • Systemic spread: Dysphagia, dysphonia, generalized muscle weakness, or respiratory compromise (symptoms of botulism).
  • Allergic reaction: Urticaria, anaphylaxis.

• Etiology:
  • Cosmetic use: Dynamic wrinkles (e.g., glabellar lines, crow’s feet) caused by repetitive muscle contractions.
  • Therapeutic use: Conditions involving muscle hyperactivity (e.g., cervical dystonia, blepharospasm) or autonomic dysfunction (e.g., hyperhidrosis, overactive bladder).
• Mechanism: Binds to presynaptic cholinergic nerve terminals and cleaves the SNAP-25 protein, preventing vesicular acetylcholine release. Effects are dose-dependent, reversible, and localized to injection sites.

• Prevention: Avoid massaging injection sites for 24 hours to prevent diffusion. Use experienced injectors to minimize risks. Gradual dose titration in new patients.
• Follow-up: Effects typically begin within 2–3 days, peak at around 2 weeks, and last 3–6 months. Schedule reinjection before full effect dissipation. Document injection patterns and doses for consistency. Monitor for late-onset side effects or diminishing efficacy.

Note: Botox is contraindicated in patients with hypersensitivity to botulinum toxin or albumin. Caution required in those taking aminoglycosides or anticoagulants. Emergency protocols should be in place for anaphylaxis or systemic toxicity.